Tekla Capital Management LLC Nevro Corp Transaction History

Tekla Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$35.52 - $62.62 $2.44 Million - $4.31 Million	-68,760 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$44.22 - $75.47 $697,349 - $1.19 Million	15,770 Added 29.76%	68,760 $3.92 Million
Q1 2018 May 14, 2018	SELL	$69.46 - $88.57 $9.84 Million - $12.5 Million	-141,631 Reduced 72.77%	52,990 $4.59 Million
Q2 2017 Aug 14, 2017	BUY	N/A	194,621	194,621 $14.5 Million

168

37.8M

44K

1.69M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $187M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.